Panorama

Taking a Super Bowl Approach to Medical Conferences

A funny thing happens when you talk “convention media.” People focus on how it ...

The Trouble with Sampling in the State of Ohio

Have you ever heard about Ohio’s Terminal Distributor of Dangerous Drugs (TDDD) licenses? Before ...

Next-Generation Forecasting Must Account for Payer Controls

The market access landscape for pharmaceutical products has shifted as payers struggle to control ...

How Drug Re-innovation Can Potentially Boost Pharma’s Depleting R&D Pipeline

The pharmaceutical industry’s typical R&D model of developing new chemical entities (NCEs) and creating ...

Transforming Hub Services and Increasing Speed to Therapy

In this final installment of a three-part series on integrating comprehensive hub services and ...

Trends that Emerged from J.P. Morgan Week 2018

Every January, tens of thousands of healthcare CEOs, investors, and business development executives descend ...

Best Practices for Forging Strategic Sponsor-CRO Relationships

A true strategic partnership has benefits for both the sponsor and the contract research ...

Reimagining Clinical Trial Registries

Since its launch in 2000, ClinicalTrials.gov has steadily grown in size and currently hosts ...

My Transition from Traditional Consulting to an Analytics Role at an Ad Agency

To the average person, both “consulting” and “analytics” tend to be perceived as floating ...

Asking the Right Questions to Influence Behaviors

“No question is a bad question,” or so we’ve been taught. As a father ...